Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,655 INR | +0.43% | +2.40% | +25.08% |
Apr. 24 | Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility | MT |
Apr. 22 | INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains | RE |
Chart calendar Lupin Limited
Upcoming events on Lupin Limited
Past events on Lupin Limited
2024-02-08 05:30 am | Q3 2024 Earnings Call |
2024-02-07 09:09 am | Q3 2024 Earnings Release |
2023-11-09 08:30 am | Q2 2024 Earnings Call |
2023-11-08 12:26 pm | Q2 2024 Earnings Release |
2023-08-04 06:30 am | Q1 2024 Earnings Call |
2023-08-03 12:30 pm | Q1 2024 Earnings Release |
2023-08-03 02:00 am | Annual General Meeting |
2023-07-13 | Ex-dividend day for final dividend |
2023-05-10 06:30 am | Q4 2023 Earnings Call |
2023-05-09 01:18 pm | Q4 2023 Earnings Release |
2023-02-10 05:30 am | Q3 2023 Earnings Call |
2023-02-09 11:25 am | Q3 2023 Earnings Release |
2023-01-09 | JP Morgan Healthcare Conference |
2022-11-10 05:30 am | Interim 2023 Earnings Call |
2022-11-09 09:43 am | Interim 2023 Earnings Release |
2022-08-04 07:30 am | Q1 2023 Earnings Call |
2022-08-03 01:05 pm | Q1 2023 Earnings Release |
2022-08-03 06:30 am | Annual General Meeting |
2022-07-13 | Ex-dividend day for final dividend |
2022-05-19 06:00 am | FY 2022 Earnings Call |
Past dividends on Lupin Limited
2023-07-13 | Annual 4 INR |
2022-07-13 | Annual 4 INR |
2021-07-26 | Annual 6.5 INR |
2020-08-02 | Annual 6 INR |
2019-07-28 | Annual 5 INR |
2018-07-29 | Annual 5 INR |
2017-07-23 | Annual 7.5 INR |
2016-07-24 | Annual 7.5 INR |
2015-07-13 | Annual 7.5 INR |
2014-07-20 | Final Payment 3 INR |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 167 182 165 998 0.71% | 153 748 158 936 -3.26% | 151 630 153 643 -1.31% | 164 055 164 611 -0.34% | 166 417 163 950 1.5% | 198 661 |
EBITDA Million INR | Released Forecast Spread | 28 822 26 290 9.63% | 23 548 24 629 -4.39% | 25 669 25 856 -0.72% | 21 656 24 161 -10.37% | 17 206 17 156 0.29% | 36 412 |
EBIT Million INR | Released Forecast Spread | 25 253 15 854 59.28% | 13 846 13 858 -0.08% | 16 795 16 555 1.45% | 5 069 14 787 -65.72% | 8 399 8 726 -3.75% | 26 419 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 15 172 16 164 -6.14% | 7 572 6 402 18.27% | 16 765 16 332 2.65% | -13 726 -2 451 -459.98% | 7 165 7 215 -0.7% | 25 289 |
Net income Million INR | Released Forecast Spread | 6 066 8 395 -27.75% | -2 694 -5 334 49.5% | 12 165 10 849 12.14% | -15 280 -4 144 -268.75% | 4 301 3 940 9.17% | 19 847 |
EPS INR | Released Forecast Spread | 13,4 19,1 -29.98% | -5,95 -7,37 19.27% | 26,7 23,9 12.02% | -33,7 -10,8 -210.97% | 9,41 8,74 7.62% | 43,3 |
Announcement Date | 15/05/19 | 28/05/20 | 12/05/21 | 18/05/22 | 09/05/23 | - |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 37 831 39 007 -3.02% | 42 702 42 253 1.06% | 40 913 40 203 1.77% | 41 609 41 880 -0.65% | 38 830 40 808 -4.85% | 37 438 40 253 -6.99% | 41 455 40 947 1.24% | 43 222 43 421 -0.46% | 44 301 42 055 5.34% | 48 141 45 076 6.8% | 48 189 | 48 810 | 50 871 | 52 043 |
EBITDA Million INR | Released Forecast Spread | 7 076 6 975 1.44% | 9 647 8 860 8.88% | 5 557 6 427 -13.54% | 3 698 6 438 -42.56% | 2 667 5 432 -50.91% | 1 639 4 183 -60.81% | 4 342 3 927 10.56% | 5 160 5 689 -9.29% | 6 041 4 985 21.17% | 8 565 6 634 29.1% | 8 076 | 8 705 | 9 950 | |
EBIT Million INR | Released Forecast Spread | 4 918 4 357 12.89% | 7 560 6 045 25.06% | -3 636 3 824 -195.09% | 1 664 3 955 -57.92% | -605 3 035 -119.95% | -289 1 771 -116.32% | 2 307 1 853 24.49% | 2 956 3 351 -11.79% | 3 401 2 828 20.26% | 6 218 4 400 41.33% | 5 627 | 5 621 | 7 472 | 7 286 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 5 184 4 658 11.29% | 7 505 5 653 32.75% | -22 048 3 813 -678.3% | 1 671 3 911 -57.28% | -852 2 956 -128.81% | 22,7 1 601 -98.58% | 2 096 1 615 29.77% | 2 461 3 175 -22.49% | 2 585 2 365 9.33% | 5 588 4 268 30.92% | 5 462 | 5 626 | 6 435 | |
Net income Million INR | Released Forecast Spread | 4 604 3 346 37.61% | 5 425 4 681 15.88% | -20 980 3 160 -763.97% | 5 455 3 005 81.54% | -5 180 2 411 -314.84% | -891 1 508 -159.08% | 1 297 1 206 7.56% | 1 535 2 447 -37.29% | 2 360 1 718 37.33% | 4 523 2 458 83.96% | 3 969 | 4 436 | 5 229 | |
EPS INR | Released Forecast Spread | 10,1 6,55 54.35% | 11,9 9,88 20.52% | -46,2 7,22 -739.94% | 12,0 6,59 81.79% | -11,4 4,80 -337.5% | -1,96 3,90 -150.26% | 2,85 3,30 -13.64% | 3,36 5,44 -38.24% | 5,16 4,53 14.03% | 9,90 6,67 48.5% | 8,27 | 9,45 | 10,4 | |
Announcement Date | 12/05/21 | 10/08/21 | 27/10/21 | 03/02/22 | 18/05/22 | 03/08/22 | 09/11/22 | 09/02/23 | 09/05/23 | 03/08/23 | - | - | - | - |
Past sector events for Lupin Limited
2024-05-03 07:07 am | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
2024-05-03 06:00 am | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
2024-05-02 04:01 pm | AMGEN INC.: Q1 2024 Earnings Release |
2024-05-02 01:43 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
2024-05-02 07:30 am | ORGANON & CO.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
2024-05-02 01:30 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
2024-05-01 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LUPIN Stock
- LUPIN Stock
- Calendar Lupin Limited